StockData
Outset Medical, Inc. logo

Outset Medical, Inc. (OM) stock

OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3077% below fair value
$3.04−0.12 (-3.80%)

Close on Nov 18, 2026Market cap $57.14MP/E –Yield –

Outset Medical free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Outset Medical's free cash flow for the twelve months ending Jun 30, 2026 was -$38.88M. For fiscal 2025 it was -$47.13M. The highest annual figure on record is -$47.13M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$47.13M–
FY2024Dec 31, 2024-$117.22M–
FY2023Dec 31, 2023-$134.81M–
FY2022Dec 31, 2022-$154.05M–
FY2021Dec 31, 2021-$133.37M–
FY2020Dec 31, 2020-$108.09M–
FY2019Dec 31, 2019-$73.59M–
FY2018Dec 31, 2018-$48.21M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.75M–
Q1 FY2026Mar 31, 2026-$12.91M–
Q4 FY2025Dec 31, 2025-$9.74M–
Q3 FY2025Sep 30, 2025-$6.48M–
Q2 FY2025Jun 30, 2025-$5.12M–
Q1 FY2025Mar 31, 2025-$25.79M–
Q4 FY2024Dec 31, 2024-$16.53M–
Q3 FY2024Sep 30, 2024-$20.96M–
Q2 FY2024Jun 30, 2024-$33.46M–
Q1 FY2024Mar 31, 2024-$46.27M–
Q4 FY2023Dec 31, 2023-$25.50M–
Q3 FY2023Sep 30, 2023-$34.78M–
Q2 FY2023Jun 30, 2023-$28.97M–
Q1 FY2023Mar 31, 2023-$45.57M–
Q4 FY2022Dec 31, 2022-$36.62M–
Q3 FY2022Sep 30, 2022-$37.05M–
Q2 FY2022Jun 30, 2022-$40.57M–
Q1 FY2022Mar 31, 2022-$39.81M–
Q4 FY2021Dec 31, 2021-$33.53M–
Q3 FY2021Sep 30, 2021-$28.62M–
Q2 FY2021Jun 30, 2021-$31.69M–
Q1 FY2021Mar 31, 2021-$39.54M–
Q4 FY2020Dec 31, 2020-$28.47M–
Q3 FY2020Sep 30, 2020-$30.58M–
Q2 FY2020Jun 30, 2020-$21.35M–
Q1 FY2020Mar 31, 2020-$27.69M–
Q4 FY2019Dec 31, 2019-$15.72M–

More Outset Medical figures

See a number that looks wrong?